
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study
Jun Ma, Jialiang Li, Jin Chen, et al.
Liver International (2022) Vol. 43, Iss. 1, pp. 221-233
Closed Access | Times Cited: 61
Jun Ma, Jialiang Li, Jin Chen, et al.
Liver International (2022) Vol. 43, Iss. 1, pp. 221-233
Closed Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study
Ning Xie, Ziwei Wang, Qiuai Shu, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2937-2937
Open Access | Times Cited: 23
Ning Xie, Ziwei Wang, Qiuai Shu, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2937-2937
Open Access | Times Cited: 23
Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study
Qing Su, Jin Chen, Zhiyuan Bo, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
Qing Su, Jin Chen, Zhiyuan Bo, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 22
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 8
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 8
Investigating the causal relationship of gut microbiota with GERD and BE: a bidirectional mendelian randomization
Yuan Liu, Jiali Yu, Yuxiao Yang, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Yuan Liu, Jiali Yu, Yuxiao Yang, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
Xujun You, Junfeng Qiu, Qixin Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Xujun You, Junfeng Qiu, Qixin Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis
Jin-Xia Liu, Jane Macnaughtan, Annarein Kerbert, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1183-1198
Open Access | Times Cited: 5
Jin-Xia Liu, Jane Macnaughtan, Annarein Kerbert, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1183-1198
Open Access | Times Cited: 5
Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
Yotsawat Pomyen, Jittiporn Chaisaingmongkol, Siritida Rabibhadana, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Yotsawat Pomyen, Jittiporn Chaisaingmongkol, Siritida Rabibhadana, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
Exploring the mediating role of blood metabolites in the relationship between gut microbiota and gastric cancer risk: a Mendelian randomization study
Xiaocheng Li, Huapeng Lin, Jing Peng, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Xiaocheng Li, Huapeng Lin, Jing Peng, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Interactions between the intestinal microbiota and drug metabolism – Clinical implications and future opportunities
Dianne Ford
Biochemical Pharmacology (2025), pp. 116809-116809
Open Access
Dianne Ford
Biochemical Pharmacology (2025), pp. 116809-116809
Open Access
Gut microbiota mediates the pro-pyroptosis effect of xierezhuyubuxu decoction in hepatocellular carcinoma
Zhili Zeng, Mingxuan Feng, He Fan, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Zhili Zeng, Mingxuan Feng, He Fan, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Application progress of early nutrition intervention in patients with hepatocellular carcinoma after liver transplantation
Shanshan Deng, Yuping Zhu, Zhitao Chen, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Shanshan Deng, Yuping Zhu, Zhitao Chen, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Global, regional and national burden of liver cancer 1990–2021: a systematic analysis of the global burden of disease study 2021
Zhichao Jiang, Guoqiang Zeng, H. L. Dai, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Zhichao Jiang, Guoqiang Zeng, H. L. Dai, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
Mario Romeo, Marcello Dallio, Filadelfo Nardo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 124-124
Open Access
Mario Romeo, Marcello Dallio, Filadelfo Nardo, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 124-124
Open Access
Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: A bidirectional Mendelian randomization study
Yu‐Feng Huang, Weiming Zhang, Zhi-Song Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Yu‐Feng Huang, Weiming Zhang, Zhi-Song Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Post-translational modifications and immune responses in liver cancer
Youwei Wang, Jiachen Zuo, Chong Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Youwei Wang, Jiachen Zuo, Chong Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma
Ping Chen, Chengchen Yang, Rende Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Ping Chen, Chengchen Yang, Rende Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma
Giuseppe Guido Maria Scarlata, Claudia Cicino, Rocco Spagnuolo, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 3
Giuseppe Guido Maria Scarlata, Claudia Cicino, Rocco Spagnuolo, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 3
Tumor microbiota of renal cell carcinoma affects clinical prognosis by influencing the tumor immune microenvironment
Hengyi Xu, Jingze Leng, Fengshuo Liu, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38310-e38310
Open Access | Times Cited: 3
Hengyi Xu, Jingze Leng, Fengshuo Liu, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38310-e38310
Open Access | Times Cited: 3
An atlas on risk factors for gastrointestinal cancers: A systematic review of Mendelian randomization studies
Yixuan Huang, Junhua Wu, Yuqiang Zhao, et al.
Preventive Medicine (2024) Vol. 189, pp. 108147-108147
Closed Access | Times Cited: 3
Yixuan Huang, Junhua Wu, Yuqiang Zhao, et al.
Preventive Medicine (2024) Vol. 189, pp. 108147-108147
Closed Access | Times Cited: 3
Causal associations between gut microbiota and cutaneous melanoma: a Mendelian randomization study
Yan-Qiu Bao, Ying Zhang, Zhou-Na Li
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Yan-Qiu Bao, Ying Zhang, Zhou-Na Li
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
In vitro digestion and fecal fermentation of Tremella fuciformis exopolysaccharides from basidiospore-derived submerged fermentation
Fang Yan, Qi Zhang, Caiyuan Yu, et al.
Food Research International (2024) Vol. 196, pp. 115019-115019
Closed Access | Times Cited: 2
Fang Yan, Qi Zhang, Caiyuan Yu, et al.
Food Research International (2024) Vol. 196, pp. 115019-115019
Closed Access | Times Cited: 2
Microbiome and its implications in oncogenesis: a Mendelian randomization perspective.
Kexin Feng, Fei Ren, Zeyu Xing, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5785-5804
Closed Access | Times Cited: 6
Kexin Feng, Fei Ren, Zeyu Xing, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5785-5804
Closed Access | Times Cited: 6
Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma—A Scoping Review
Ann‐Kathrin Lederer, Hannah Rasel, Eva Kohnert, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 5
Ann‐Kathrin Lederer, Hannah Rasel, Eva Kohnert, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 5